Ligand Pharmaceuticals Inc Investor and Analyst Day Transcript
Simon Latimer and I head Investor Relations at Ligand Pharmaceuticals and webcast. It's great to be back in person. Presenting today for Ligand will be Todd Davis, Chief Executive Officer; Matt Korenberg, President and Chief Operating Officer; Diane Retallack, Senior Vice President of Platform Technologies and Innovation; Andrew Reardon, Chief Legal Officer; Octavio Espinoza, Chief Financial Officer.
First, a few housekeeping items. Following the presentation, we will have a Q&A session, and we ask that you hold your questions until that time. Those joining by the webcast will have an opportunity to ask questions as well. We'll be using slides to guide our discussion today. We will also be using non-GAAP financial measures and some of our statements will be forward-looking.
Additional information regarding the risk factors and other matters concerning Ligand can be found in our summary press release issued earlier today, the slides associated with this event and our periodic filings with the SEC. Ligand undertakes no
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |